Secondary Prevention of Coronary Heart Disease in Elderly Patients Following Myocardial Infarction: Are All HMG-CoA Reductase Inhibitors Alike?

Author： Maroo Bijesh P.   Lavie Carl J.   Milani Richard V.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.25, Iss.8, 2008-01, pp. : 649-664

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of HMG-CoA Reductase Inhibitors: Optimizing the Prevention of Coronary Heart Disease

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 1, 2009-03 ,pp. : 1-26

Bentham Science Publishers

Access to resources Recommend Favorite

HMG-CoA reductase inhibitors improve heart rate variability in patients with a previous myocardial infarction

By Riahi S.   Hagstrup Christensen J.   Toft E.   Aarup Skou H.   Berg Schmidt E.  

Pharmacological Research, Vol. 45, Iss. 6, 2002-06 ,pp. : 479-483

Academic Press

Access to resources Recommend Favorite

Effects of HMG-CoA Reductase Inhibitors on Skeletal Muscle: Are all Statins the Same?

By Evans M.   Rees A.  

Drug Safety, Vol. 25, Iss. 9, 2002-01 ,pp. : 649-663

Adis International

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors: Do They Have Potential in the Treatment of Polycystic Ovary Syndrome?

By Kodaman Pinar H.  

Drugs, Vol. 68, Iss. 13, 2008-01 ,pp. : 1771-1785

Adis International

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors in Osteoporosis: Do They Reduce the Risk of Fracture?

By Schlienger R.G.   Meier C.R.  

Drugs & Aging, Vol. 20, Iss. 5, 2003-01 ,pp. : 321-336

Adis International

Access to resources Recommend Favorite